 Biolase Inc NASDAQ: BIOL shares are trading higher on strong volume after it reported Q2 sales of 9.1 million, 211 YY, edging out a consensus of 8.31 million. Over 70 of U.S. laser sales came from new customers, continuing a positive trend, and more than 35 of U.S. Waterlase sales came from dental specialists. 